U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C15H12N4S
Molecular Weight 280.348
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AGL-2043

SMILES

CN1C(C)=NC2=C1C=C3N=CC(=NC3=C2)C4=CC=CS4

InChI

InChIKey=ZGDACLBJJXLKJY-UHFFFAOYSA-N
InChI=1S/C15H12N4S/c1-9-17-12-6-11-10(7-14(12)19(9)2)16-8-13(18-11)15-4-3-5-20-15/h3-8H,1-2H3

HIDE SMILES / InChI

Molecular Formula C15H12N4S
Molecular Weight 280.348
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Tricyclic quinoxalines as potent kinase inhibitors of PDGFR kinase, Flt3 and Kit.
2003 May 1
Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity.
2011 Oct 30
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
2013 Apr 15
Substance Class Chemical
Created
by admin
on Sat Dec 16 09:00:28 GMT 2023
Edited
by admin
on Sat Dec 16 09:00:28 GMT 2023
Record UNII
8OO2SLF34L
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AGL-2043
Common Name English
1H-IMIDAZO(4,5-G)QUINOXALINE, 1,2-DIMETHYL-6-(2-THIENYL)-
Systematic Name English
Code System Code Type Description
FDA UNII
8OO2SLF34L
Created by admin on Sat Dec 16 09:00:28 GMT 2023 , Edited by admin on Sat Dec 16 09:00:28 GMT 2023
PRIMARY
CAS
226717-28-8
Created by admin on Sat Dec 16 09:00:28 GMT 2023 , Edited by admin on Sat Dec 16 09:00:28 GMT 2023
PRIMARY
PUBCHEM
9817165
Created by admin on Sat Dec 16 09:00:28 GMT 2023 , Edited by admin on Sat Dec 16 09:00:28 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY